Back to search

PES-HORISONT-EU-PES Horisont Europa

AI-enhanced colon cancer detection

Awarded: NOK 74,999

Augere has developed a breakthrough solution, named PolypAid™, an Artificial Intelligence (AI) based Computer-Aided Detection (CADe) system to detect polyps in real-time during colonoscopy. The system integrated with existing equipment and workflow receives the video signal and analyses it in real-time using advanced AI models. Our solution offers superior detection with a best-in-class combination of high sensitivity and specificity, with the ability to detect the most elusive polyps, such as flat and sessile, which are often missed during colonoscopies. Our in-silico clinical trials, with 300 patients, showed a sensitivity of 98.4% in detecting lesions and 100% in sessile serrated polyps. PolypAid™ will guide endoscopists during colonoscopies and improve overall performance to increase adenoma detection rates (ADR). Consequently, patients will receive consistently high-quality colorectal cancer (CRC) screening. By improving ADR, PolypAid™ will contribute to reduced CRC cancer rates.

Funding scheme:

PES-HORISONT-EU-PES Horisont Europa